Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01727336
Title Study of Dalantercept in Patients With Advanced Renal Cell Carcinoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Acceleron Pharma, Inc.
Age Groups: adult
Covered Countries USA

No variant requirements are available.